Soliris 300 mg/30 mL (10 mg/mL) injection Images

Generic Name: eculizumab

This medication has been identified as Soliris 300 mg/30 mL (10 mg/mL) injection. It is supplied by Alexion Pharmaceuticals Inc.

Soliris is used in the treatment of Myasthenia Gravis; Hemolytic Uremic Syndrome; Neuromyelitis Optica Spectrum Disorder; Paroxysmal Nocturnal Hemoglobinuria and belongs to the drug class selective immunosuppressants. Risk cannot be ruled out during pregnancy. Soliris 300 mg/30 mL (10 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Soliris

Generic Name

eculizumab

Strength

300 mg/30 mL (10 mg/mL) injection

Availability

Prescription only

Drug Class

Selective immunosuppressants

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Alexion Pharmaceuticals Inc.

National Drug Code (NDC)

25682-0001

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer